SavedAdd your journal

Journals / Hacettepe Journal of Biology and Chemistry / 2022 / Cilt: 50 - Sayı: 1

TMEM106C is overexpressed and modulates cell mobility in metastatic colon cancer cells

Muzaffer DÜKEL
Pages
77–84
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, we showed that TMEM106C gene is important for colon carcinoma cells.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Colon cancer is the third most commonly diagnosed cancer in men worldwide.
📊
Key Findings & Data:TMEM106C is a TMEM family protein, but its role on colon cancer development is unknown.
💡
Conclusion & Impact:In conclusion, we showed that TMEM106C gene is important for colon carcinoma cells.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Colon cancer · TMEM106C · Metastasis

Abstract

Colon cancer is the third most commonly diagnosed cancer in men worldwide. Colon cancer grows slowly and metastasis has already occurred after diagnosis. Therefore, new targets are needed in the colon cancer treatment and diagnosis. Transmembrane proteins (TMEM) play a critical role and presents different expression profile in variety of tumor cells. TMEM106C is a TMEM family protein, but its role on colon cancer development is unknown. In this study, we aimed to investigate TMEM106C gene in metastatic colon cancer cells. TMEM106C gene expression level was tested by western blot, qRT-PCR and immunofluorescence methods. In order to test the effect of TMEM106C in colon cancer cells, this gene has been knockdown with shRNA technology. In addition, cell invasion, migration and adhesion assays were performed to clarify whether TMEM106C knockdown has effect on colon cancer metastatic characters. Ford the first time, in this study, we showed TMEM106C is overexpressed in colon carcinoma cells. Moreover, we demonstrated that cell migration, invasion and adhesion capabilities are reduced in TMEM106C silenced cells. Furthermore, we observed that metastatic cell morphology was changed upon to TMEM106C knockdown. In conclusion, we showed that TMEM106C gene is important for colon carcinoma cells.

🔖

Cite This Article

DÜKEL, M. (2022). TMEM106C is overexpressed and modulates cell mobility in metastatic colon cancer cells. Hacettepe Journal of Biology and Chemistry, Cilt: 50 - Sayı: 1, 77–84. https://ajindex.com/articles/528910

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 68, (2018) 394–424.
  2. P. Rawla, T. Sunkara, A. Barsouk, Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz. Gastroenterol. 14, (2019) 89–103.
  3. T.N. Seyfried, L.C. Huysentruyt, On the origin of cancer metastasis. Crit. Rev. Oncog. 18, (2013) 43–73. H. Dillekås, M.S. Rogers, O. Straume, Are 90% of deaths from cancer caused by metastases? Cancer Med. 8, (2019) 5574–5576.
  4. J.A. Joyce, J.W. Pollard, Microenvironmental regulation of metastasis. Nat. Rev. Cancer. 9, (2009) 239–252.
  5. S. Sakamoto, N. Kyprianou, Targeting anoikis resistance in prostate cancer metastasis. Mol. Aspects Med. 31, (2010) 205–214.
  6. G. Bendas, L. Borsig, Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. Int. J. Cell Biol. 2012, (2012) 676731. U. Cavallaro, G. Christofori, Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim. Biophys. Acta. 1552, (2001), 39–45.
  7. K. Schmit, C. Michiels, TMEM Proteins in Cancer: A Review, Frot Pharmacol. 9, (2018) 1345. S. Marx, T. Dal Maso, J.-W. Chen, M. Bury, J. Wouters, C. Michiels, B. Le Calvé, Transmembrane (TMEM) protein family members: Poorly characterized even if essential for the metastatic process. Semin. Cancer Biol. 60, (2020) 96–106. S. Hrašovec, N. Hauptman, D. Glavač, F. Jelenc, M. Ravnik-Glavač, TMEM25 is a candidate biomarker methylated and down-regulated in colorectal cancer. Dis. Markers. 34, (2013) 93–104.
  8. Y. Wang, Y. Zhang, J.G. Herman, E. Linghu, M. Guo, Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development. Oncotarget. 8, (2017) 70035–70048.
  9. W. Qiao, Y. Han, W. Jin, M. Tian, P. Chen, J. Min, H. Hu, B. Xu, W. Zhu, L. Xiong, Q. Lin, Overexpression and biological function of TMEM48 in non-small cell lung carcinoma. Tumour Biol. 37, (2016) 2575–2586.
  10. L. Flamant, E. Roegiers, M. Pierre, A. Hayez, C. Sterpin, O. De Backer, T. Arnould, Y. Poumay, C. Michiels, TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cells. BMC Cancer. 12, (2012) 391. J. Guo, L. Chen, N. Luo, W. Yang, X. Qu, Z. Cheng, Inhibition of TMEM45A suppresses proliferation, induces cell cycle arrest and reduces cell invasion in human ovarian cancer cells. Oncol. Rep. 33, (2015) 3124–3130.